Drug Shortage Report for CERUBIDINE

Last updated on 2020-01-02 History
Report ID 97019
Drug Identification Number 01926683
Brand name CERUBIDINE 20MG/VIAL
Common or Proper name CERUBIDINE
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) DAUNORUBICIN
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size VIAL
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-10-25
Actual start date 2019-10-22
Estimated end date 2019-12-27
Actual end date 2019-12-21
Shortage status Resolved
Updated date 2020-01-02
Company comments AVAILABLE UNDER ALLOCATION
Health Canada comments
Tier 3 Status No
Contact Address 8250 BLVD DECARIE, SUITE 110
MONTREAL, QUEBEC
CANADA H4P 2P5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-02 French Compare
v4 2020-01-02 English Compare
v3 2019-10-23 English Compare
v2 2019-10-22 French Compare
v1 2019-10-22 English Compare

Showing 1 to 5 of 5